New pill aims to stop early lung cancer from coming back
NCT ID NCT07330076
Summary
This study is testing whether taking Iruplinalkib tablets after surgery can help prevent early-stage lung cancer from returning. The trial will involve 28 patients who have had surgery for a specific genetic type of lung cancer and have certain risk factors. Researchers will track patients for three years to see if the medication reduces cancer recurrence while monitoring for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.